Biden Pulls the trigger: Vaccine Mandate

[fast4522]

Vermont has the highest vaccination rate in the country. So why are cases surging?

https://abcnews.go.com/Health/vermon...ry?id=81090116

[Elkchester Road]

Originally Posted by fast4522

Vermont has the highest vaccination rate in the country. So why are cases surging?

https://abcnews.go.com/Health/vermon...ry?id=81090116

fast4522...let's see if mostpost touches this.

[boxcar]

Originally Posted by fast4522

Vermont has the highest vaccination rate in the country. So why are cases surging?

https://abcnews.go.com/Health/vermon...ry?id=81090116

That's easy. The vaxxes are great; it's the vaxxees who are defective.

[Elkchester Road]

Originally Posted by boxcar

That's easy. The vaxxes are great; it's the vaxxees who are defective.

[taxicab]

Twitter

[boxcar]

Originally Posted by taxicab

https://twitter.com/bev_coomler/stat...77964878721031

Censorship keeps the numbers down by hiding the data.

[xtb]

Originally Posted by taxicab

https://twitter.com/bev_coomler/stat...77964878721031

The CDC is not keeping infection rate data on those unvaccinated who have recovered from covid. Bongino read a letter from the CDC in response to a FOIA request. The data would most certainly spoil the narrative so don't collect it.

[boxcar]

Originally Posted by xtb

The CDC is not keeping infection rate data on those unvaccinated who have recovered from covid. Bongino read a letter from the CDC in response to a FOIA request. The data would most certainly spoil the narrative so don't collect it.

I don't believe anyone with natural immunity has ever become reinfected. So, natural immunity is batting 1000, whereas vaxx immunity for those reinfected is way under that.

[Jeff P]

Originally Posted by boxcar

I don't believe anyone with natural immunity has ever become reinfected. So, natural immunity is batting 1000, whereas vaxx immunity for those reinfected is way under that.

I wouldn't go that far.

An Israeli study published in August 2021 looked at breakthrough infections among the vaccinated vs. reinfections among those confirmed as having Covid infections in the past.

There were reinfections in the data.

That said, I'm still amazed how government policy makers not just here in the US (but planet-wide) downplay the topic of Natural Immunity as if it doesn't exist.

Imo, if the objective behind government policy really was using science to get the best possible outcome for the population of a nation, a state, a city, etc., at the very least:

Natural Immunity would be a huge part of the conversation - as would therapeutics and early treatment protocols.

Btw, the study linked to below (and others like it) were used by the Israeli government as the basis for recommending booster shots.

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections:
https://www.medrxiv.org/content/10.1...15v1.full-text

Sivan Gazit, Roei Shlezinger, Galit Perez, Roni Lotan, Asaf Peretz, Amir Ben-Tov, Dani Cohen, Khitam Muhsen, Gabriel Chodick, Tal Patalon

doi: https://doi.org/10.1101/2021.08.24.21262415

This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

I know... the above quoted blue text says preprint (not peer reviewed.)

That said, this same study, as well as others like it, are cited in a number of studies our own FDA and CDC have ended up using to shape policy here in the US (albeit while ignoring Natural Immunity.)

Scroll down about one quarter of the way from the top of the page:

____________________________________
Results

Overall, 673,676 MHS members 16 years and older were eligible for the study group of fully vaccinated SARS-CoV-2-naïve individuals; 62,883 were eligible for the study group of unvaccinated previously infected individuals and 42,099 individuals were eligible for the study group of previously infected and single-dose vaccinees.

Model 1 – previously infected vs. vaccinated individuals, with matching for time of first event

In model 1, we matched 16,215 persons in each group. Overall, demographic characteristics were similar between the groups, with some differences in their comorbidity profile (Table 1a).

View inline View popup

Table 1a.

Characteristics of study population, model 1 and 2.

View inline View popup

Table 1b.

Characteristics of study population, model 3.

During the follow-up period, 257 cases of SARS-CoV-2 infection were recorded, of which 238 occurred in the vaccinated group (breakthrough infections) and 19 in the previously infected group (reinfections). After adjusting for comorbidities, we found a statistically significant 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection as opposed to reinfection (P<0.001). Apart from age ≥60 years, there was no statistical evidence that any of the assessed comorbidities significantly affected the risk of an infection during the follow-up period (Table 2a). As for symptomatic SARS-COV-2 infections during the follow-up period, 199 cases were recorded, 191 of which were in the vaccinated group and 8 in the previously infected group. Symptoms for all analyses were recorded in the central database within 5 days of the positive RT-PCR test for 90% of the patients, and included chiefly fever, cough, breathing difficulties, diarrhea, loss of taste or smell, myalgia, weakness, headache and sore throat. After adjusting for comorbidities, we found a 27.02-fold risk (95% CI, 12.7 to 57.5) for symptomatic breakthrough infection as opposed to symptomatic reinfection (P<0.001) (Table 2b). None of the covariates were significant, except for age ≥60 years.

View inline View popup

Table 2a.

OR for SARS-CoV-2 infection, model 1, previously infected vs. vaccinated

View inline View popup

Table 2b.

OR for Symptomatic SARS-CoV-2 infection, model 1, previously infected vs. vaccinated

Nine cases of COVID-19-related hospitalizations were recorded, 8 of which were in the vaccinated group and 1 in the previously infected group (Table S1). No COVID-19-related deaths were recorded in our cohorts.

Model 2 –previously infected vs. vaccinated individuals, without matching for time of first event

In model 2, we matched 46,035 persons in each of the groups (previously infected vs. vaccinated). Baseline characteristics of the groups are presented in Table 1a. Figure 1 demonstrates the timely distribution of the first infection in reinfected individuals. When comparing the vaccinated individuals to those previously infected at any time (including during 2020), we found that throughout the follow-up period, 748 cases of SARS-CoV-2 infection were recorded, 640 of which were in the vaccinated group (breakthrough infections) and 108 in the previously infected group (reinfections). After adjusting for comorbidities, a 5.96-fold increased risk (95% CI, 4.85 to 7.33) for breakthrough infection as opposed to reinfection could be observed (P<0.001) (Table 3a). Apart from SES level and age ≥60, that remained significant in this model as well, there was no statistical evidence that any of the comorbidities significantly affected the risk of an infection.

Discussion

This is the largest real-world observational study comparing natural immunity, gained through previous SARS-CoV-2 infection, to vaccine-induced immunity, afforded by the BNT162b2 mRNA vaccine. Our large cohort, enabled by Israel’s rapid rollout of the mass-vaccination campaign, allowed us to investigate the risk for additional infection – either a breakthrough infection in vaccinated individuals or reinfection in previously infected ones – over a longer period than thus far described.

Our analysis demonstrates that SARS-CoV-2-naïve vaccinees had a 13.06-fold increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021. The increased risk was significant for a symptomatic disease as well.

Broadening the research question to examine the extent of the phenomenon, we allowed the infection to occur at any time between March 2020 to February 2021 (when different variants were dominant in Israel), compared to vaccination only in January and February 2021. Although the results could suggest waning natural immunity against the Delta variant, those vaccinated are still at a 5.96-fold increased risk for breakthrough infection and at a 7.13-fold increased risk for symptomatic disease compared to those previously infected. SARS-CoV-2-naïve vaccinees were also at a greater risk for COVID-19-related-hospitalization compared to those who were previously infected.

-jp

.

[davew]

RFK Jr says covid vaccine has killed more people than all other vaccines combined in recorded history


https://www.dailymail.co.uk/news/art...-combined.html

[Jeff P]

Twitter

It's a good thing Twitter has censors working 'round the clock labeling videos by Doctors as 'misleading.'

Otherwise I might get the idea mRNA vaccines have side effects.



-jp

.

__________________
Team JCapper: 2011 PAIHL Regular Season ROI Leader after 15 weeks
www.JCapper.com

[Elkchester Road]

Originally Posted by Jeff P

https://twitter.com/i/status/1459675860458524677


It's a good thing Twitter has censors working 'round the clock labeling videos by Doctors as 'misleading.'

Otherwise I might get the idea mRNA vaccines have side effects.



-jp

.

Thank you for posting this video, Jeff...before it gets 86'd.

[tbwinner]

If you think the mandate is toast, just know the fix is in.

You only need to read the headline and one sentence to realize this.

. The office denied a request by The Associated Press to allow media access to the drawing.

https://m.washingtontimes.com/news/2...-vaccine-mand/

[boxcar]

Originally Posted by Elkchester Road

Thank you for posting this video, Jeff...before it gets 86'd.

"Weakening the immune system" this doctor said in the vid. Ya think?

[JustRalph]

Got an email blast

All cases are headed for the 6th circuit

That court is known to be right leaning.

Cross your fingers